John C. Martin
2010 - Gilead Sciences
In 2010, John C. Martin earned a total compensation of $14.2M as Chairman and Chief Executive Officer at Gilead Sciences, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,325,375 |
|---|---|
| Option Awards | $4,821,834 |
| Salary | $1,341,679 |
| Stock Awards | $5,750,500 |
| Other | $5,000 |
| Total | $14,244,388 |
Martin received $5.8M in stock awards, accounting for 40% of the total pay in 2010.
Martin also received $2.3M in non-equity incentive plan, $4.8M in option awards, $1.3M in salary and $5K in other compensation.
Rankings
In 2010, John C. Martin's compensation ranked 158th out of 10,439 executives tracked by ExecPay. In other words, Martin earned more than 98.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 158 out of 10,439 | 99th |
Division Manufacturing | 52 out of 3,838 | 99th |
Major group Chemicals And Allied Products | 12 out of 921 | 99th |
Industry group Drugs | 8 out of 680 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 142 | 99th |
Source: SEC filing on March 19, 2013.
Martin's colleagues
We found five more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2010.
2010
John Milligan
Gilead Sciences
Chief Operating Officer
2010
Kevin Young
Gilead Sciences
Executive Vice President, Commercial Operations
2010
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2010
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2010
Robin Washington
Gilead Sciences